Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors
Clinical trial NCT02843204 · COMPLETED
Trial details
- NCT number
- NCT02843204
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-07-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.